Kiwi Biosciences
Patent-pending enzymes to break down common dietary triggers
Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.
- Website
- fodzyme.com
- City
- Boston
- Country
- United States
- YC batch
- Summer 2021
- Team
- 10 people
- Stage
- Early stage
- AI-native
- No
More Health & bio in Boston
WHOOP$10.1bn
Wearable technology. Valued at $10.1bn (March 2026).
Ginkgo BioworksHiring
Our mission is to make biology easier to engineer.
Modern HealthHiring
A mental health benefits platform for employers.
TetraScience
The only R&D data cloud for life sciences
OpenBiome
A nonprofit stool bank enabling access to fecal transplants.
SiPhox HealthHiring
At-Home health monitoring with silicon photonic chips for data centers
Claim this profile
Free and instant: prove you run fodzyme.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Kiwi Biosciences across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Kiwi Biosciences's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
